Silk Road Medical Inc. (SILK) Tops Q2 EPS by 5c

July 29, 2021 4:41 PM EDT

Get inside Wall Street with StreetInsider Premium. Claim your 1-week free trial here.

Silk Road Medical Inc. (NASDAQ: SILK) reported Q2 EPS of ($0.31), $0.05 better than the analyst estimate of ($0.36). Revenue for the quarter came in at $26.5 million versus the consensus estimate of $25.34 million.

GUIDANCE:

Silk Road Medical Inc. sees Q3 2021 revenue of $104-109 million, versus the consensus of $106.04 million.

For earnings history and earnings-related data on Silk Road Medical Inc. (SILK) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings, Guidance

Related Entities

Earnings